Transactions
Our track record speaks to the ambition and success of the companies we support.
Explore a selection of the capital raises, acquisitions, and public market transactions we've advised on.
-
Aquis
Delta Gold Technologies Plc
£8m IPO
Corporate Advisor
January 2026 -
TSX
55 North Mining Inc.
$4m Secondary Fundraise
Broker
Nov 2025 -
AIM
Ondine Biomedical pls
£11m Secondary Fundraise
Lead Broker
Aug 2025 -
AIM
Wellnex Life Ltd
£35m Dual listing
Corporate Advisor & Broker
March 2025 -
AIM
Ondine Biomedical plc
£9m Secondary Placing
Joint Bookrunner
November 2024 -
AIM
Goldstone Resources Ltd
£600,000 Secondary Placing
August 2024 -
AIM
Roquefort Therapeutics plc
£665,000 CLN Funding
Broker
May 2024 -
AIM
Oracle Power plc
£360,000 Secondary Placing
Broker
May 2024 -
AIM
Cadence Minerals plc
£500,000 Secondary Placing
Broker
April 2024 -
AIM
Helix Exploration plc
£17m IPO
Corporate advisor & Broker
April 2024 -
AIM Admission++
Smarttech247 Group PLC
Mkt Cap @ Admission - £36.80m
IFRS Conversion and ongoing Annual and Interim Financial Reporting Support
November 2022 -
LSE
Graft Polymer (UK) plc
£22m IPO
Corporate Advisor
January 2022 -
AIM Admission
Eneraqua Technologies plc
Mkt Cap @ Admission - £92.0m
IFRS Conversion & Reporting Accounting Support
November 2021 -
AIM
Bens Creek Group plc
£35m IPO
Joint broker
October 2021 -
Aquis
Helium Ventures pls
£2m SPAC listing
Corporate Advisor
April 2021 -
LSE
MGC Pharma plc
£33m LSE dual listing
Corporate Advisors
February 2021 -
AIM
Helium One plc
£15.5m RTO
Corporate Advisor & Broker
Dec 2020 -
RTO & AIM Admission
RTO of Alexander Mining
Mkt Cap @ Admission - £9.80m
IFRS Conversion & ongoing Annual & Interim Financial Reporting Support
January 2020 -
Private
Payapps
Corporate Advisor & broker
£55m funding
2015-2017 -
S-Ventures plc
Annual Financial Statements
Full Group Consolidation & Annual Financial Report Services